Brian Lian
2021
In 2021, Brian Lian earned a total compensation of $4.1M as Chief Executive Officer at Viking Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $278,000 |
|---|---|
| Option Awards | $1,522,519 |
| Salary | $594,000 |
| Stock Awards | $1,664,600 |
| Total | $4,059,119 |
Lian received $1.7M in stock awards, accounting for 41% of the total pay in 2021.
Lian also received $278K in non-equity incentive plan, $1.5M in option awards and $594K in salary.
Rankings
In 2021, Brian Lian's compensation ranked 3,307th out of 12,406 executives tracked by ExecPay. In other words, Lian earned more than 73.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,307 out of 12,406 | 73rd |
Division Manufacturing | 1,343 out of 5,494 | 76th |
Major group Chemicals And Allied Products | 545 out of 2,369 | 77th |
Industry group Drugs | 484 out of 2,090 | 77th |
Industry Pharmaceutical Preparations | 335 out of 1,537 | 78th |
Source: SEC filing on April 7, 2022.
Lian's colleagues
We found two more compensation records of executives who worked with Brian Lian at Viking Therapeutics in 2021.
News
Viking Therapeutics CEO Brian Lian's 2021 pay falls 22% to $4.1M
April 7, 2022
Viking Therapeutics CEO Brian Lian's 2020 pay jumps 48% to $5.2M
April 8, 2021
Viking Therapeutics CEO Brian Lian's 2019 pay jumps 150% to $3.5M
April 6, 2020
Viking Therapeutics CEO Brian Lian's 2018 pay jumps 74% to $1.4M
April 5, 2019